Background: Dysbiosis of gut microbiota plays a pivotal role in vascular dysfunction and
microbial diversity was reported to be inversely correlated with arterial stiffness. However …

Gut microbiota dysbiosis has been considered to be an important risk factor that contributes
to coronary artery disease (CAD), but limited evidence exists about the involvement of gut …

Wide-scale profiling technologies including metabolomics broaden the possibility of novel
discoveries related to the pathogenesis of type 2 diabetes (T2D). By applying non-targeted …

The collection of normally non-pathogenic microorganisms that mainly inhabit our gut lumen
shapes our health in many ways. Structural and functional perturbations in the gut microbial …

Considering the prevalence of cardiovascular disease (CVD), significant interest has been
focused on the gut microbiota‐heart interaction because the gut microbiota has been …

In the last two decades, considerable interest has been shown in understanding the
development of the gut microbiota and its internal and external effects on the intestine, as …

Background The gut microbiota was shown to play a crucial role in the development of
vascular dysfunction, and the bacterial composition differed between healthy controls and …

In this review, we discuss the molecular mechanisms of gut microbiome contributing to CVD,
which include gut microbes translocalization to aortic artery because of gut barrier defect to …

Summary Using untargeted metabolomics (n= 1,162 subjects), the plasma metabolite (m/z=
265.1188) phenylacetylglutamine (PAGln) was discovered and then shown in an …

Cardiovascular diseases (CVD) are major causes of death worldwide. Recently, new roles
for intestinal microbiota in pathology and treatment of CVD have been proposed. Butyrate, a …